Value of antifungal prophylaxis with antifungal drugs against oropharyngeal candidiasis in cancer patients
- 1 January 1994
- journal article
- research article
- Published by Elsevier in Oral Oncology
- Vol. 30 (3) , 196-199
- https://doi.org/10.1016/0964-1955(94)90091-4
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Antifungal Prophylaxis in Bone Marrow TransplantationClinical Infectious Diseases, 1990
- Prophylaxis of Oropharyngeal Candidiasis with FluconazoleClinical Infectious Diseases, 1990
- Recent developments in prophylaxis and therapy of invasive fungal infections in granulocytopenic cancer patientsEuropean Journal of Cancer and Clinical Oncology, 1988
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985
- Prevention of Mycosis in Granulocytopenic Patients with Prophylactic Ketoconazole Treatment/Prophylaktische Mykose‐Behandlung mit Ketoconazol bei granulozytopenischen PatientenMycoses, 1983
- Bacteriological aspects of selective decontamination of the digestive tract as a method of infection prevention in granulocytopenic patientsAntimicrobial Agents and Chemotherapy, 1981
- Infection prevention in granulocytopenic patients by selective decontamination of the digestive tractPublished by Elsevier ,1980
- Clinical experience in prevention of candidiasis by nystatin in children with acute lymphocytic leukemiaThe Journal of Pediatrics, 1978
- Prophylactic Treatment with Miconazole in Patients Highly Predisposed to Fungal InfectionActa Medica Scandinavica, 1978
- Oral anticandidal prophylaxis in patients undergoing chemotherapy for acute leukemiaMedical and Pediatric Oncology, 1977